• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1998 Fiscal Year Final Research Report Summary

Gene Therapy in the Cardiovascular Disease

Research Project

Project/Area Number 09044299
Research Category

Grant-in-Aid for international Scientific Research

Allocation TypeSingle-year Grants
SectionJoint Research
Research Field Circulatory organs internal medicine
Research InstitutionOsaka University

Principal Investigator

OGIHARA Toshio  Osaka University Faculty of Medicine, Professor, 医学部, 教授 (60107042)

Co-Investigator(Kenkyū-buntansha) DZAU Victor J  Harvard University Faculty of Medicine, Professor, 医学部, 教授
MORISHITA Ryuichi  Osaka University Faculty of Medicine, Associate Professor, 医学部, 助教授 (40291439)
MORIGUCHI Atushi  Osaka University Faculty of Medicine, Assistant Professor, 医学部, 助手 (10273666)
KANEDA Yasufumi  Osaka University Faculty of Medicine, Professor, 医学部, 教授 (10177537)
HIGAKI Jituo  Osaka University Faculty of Medicine, Associate Professor, 医学部, 助教授 (70189744)
Project Period (FY) 1997 – 1998
Keywordsgene therapy / HGF / decoy / restenosis / peripheral arterial disease
Research Abstract

Recently, gene therapy has been center of interests in the treatment of cardiovascular disease. One of major targets for gene therapy is restenosis after angioplasty. To achieve the complete inhibition of neointimal formation, we have identified cell cycle regulatory proteins as a target. Application of decoy strategy to regulate the transcription of disease-related genes has important therapeutic potentials. Thus, decoy against transcription factor E2F that is essential for cell proliferation resulted in the complete inhibition of neointimal formation up to 8 weeks after transfection. We also employed porcine coronary artery balloon injury model. Transfection of E2F decoy ODN using hydrogel catheter resulted in a significant inhibition of neointimal formation. Currently, we plan to start human gene therapy trial using E2F decoy to treat restenosis after angioplasty.
Alternatively, we also focused on the therapeutic angiogenesis strategy using human hepatocyte growth factor (HGF) gene. Number of vessels in rat hindlimb transfected with HGF gene was significantly. increased, accompanied by a significant increase in blood flow. Thus, we provided direct in vivo evidence for angiogenesis induced by HGF gene in rat ischemic hindlimb model. Based upon these findings, we submitted the clinical protocol of human gene therapy using HGE to treat peripheral arterial disease to Osaka University.

  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Yamada K. Moriguchi A.: "Efficient oligonucleotides delivery using HVJ-liposome method in the central nervous system" Hypertension. 28. 409-413 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hayashi S., Morishita R.: "In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluid" Gene Therapy. 3. 878-885 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Morishita R., Gibbons G.H.: "Molecular delivery system for antisense olgonucleotides ; enhanced effectiveness of antisense oligonucleotides by HVJ-liposome mediated transfer" Journal of Cardiovascular Pharmacology & Therapeutics. 2. 213-222 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Aoki M., Morishita R.: "Survival of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and β-galactosidase gene in non-infarcted area, but not myocardial infarcted area" Gene Therapy. 4. 120-127 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Aoki M., Morishita R.: "Efficient in vivo gene transfer into heart in rat myocardial infarction model using HVJ (Hemagglutinating Virus of Japan) liposome method" J Mol Cell Cardiol. 29. 949-959 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Morishita R., Sugimoto T.: "In vivo transfection of cis element “decoy" against NFKB binding site prevented myocardial infarction as gene therapy" Nature Medicine. 3. 894-899 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Morishita R., Aoki M.: "Kluwer Academic publisyers" Gene therapy for myocardial infarction, 531-550 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Morishita R., Aoki M.: "Kluwer Academic Publishers" Function analysis of tissue renin-angiotensin System using “Gain and Loss of Function" Approaches ; In vivo test of in vitro hypothesis. in “Angiotensin II receptor blockade ; physiological, in press (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamada K,Moriguchi A,Morishita R,Aoki M,Nakamura Y,Mikami H,Oshima T,Ninomiya M,Kaneda Y,Higaki J,Ogihara T.: "Efficient oligonucleotides delivery using HVJ-liposome method in the central nervous system." Hypertension. 28. 409-413 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hayashi S,Morishita R,Aoki M,Moriguchi A,Kida I,Nakajima M,Kaneda Y,Higaki J,Ogihara T.: "In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluid." Gene Therapy. 3. 878-885 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Morishita R,Gibbos GH,Horiuchi M,Nakajima M,Ellison KE,Lee W,Kaneda Y,Ogihara T,Dzau VJ.: "Molecular delivery system for antisense olgonucleotides : enhanced effectiveness of antisense oligonucleotides by HVJ-liposome mediated transfer." Journal of Cardiovascular Pharmacology & Therapeutics. 2. 213-222 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Aoki M,Morishita R,Higaki J,Moriguchi A,Hayashi S,Matsushita H,Kida I,Tomita N,Sawa Y,Kaneda Y,Ogihara T.: "Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and beta-galactosidase gene in non-infarcted area, but not myocardial infarcted area." Gene Therapy. 4. 120-127 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Aoki M,Morishita R,Muraishi A,Moriguchi A,Sugimoto T,Maeda K,Dzau VJ,Kaneda Y,Higaki J,Ogihara T.: "Efficient in vivo gene transfer into heart in rat myocardial infarction model using HVJ (Henagglutinating Virus of Japan )-liposome method." J Mol Cell Cardiol. 29. 949-959 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Morishita R,Sugimoto T,Aoki M,Kida I,Tomita N,Moriguchi A,Maeda K,Sawa Y,Kaneda Y,Higaki J,Ogihara T.: "In vivo transfection of cis element "decoy"against NFkB binding site prevente myocardial infarction as gene therapy." Nature Medicine. 3. 894-899 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki J,Isobe M,Morishita R,Aoki M,Horie S,Okubo Y,Kaneda Y,Sawa Y,Matsuda H,Ogihara T,Sekiguchi M.: "Prevention of graft coronary arteriosclerosis by antisense cdk 2 kinase oligonucleotide." Nature Medicine. 3. 900-903 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Morishita R,Gibbons GH,Horiuchi M,Kaneda Y,Ogihara T,Dzau VJ.: "Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells : using decoy approach against AP-1 binding site." Biochemical Biophysics Research Communication. 243. 361-367 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Morishita R,Higaki J,Tomita N,Ogihara T.: "Application of transcription factor "decoy"strategy as means of gene therapy and study of gene expression in cardiovascular disease." Circulation Reserch. 82. 1023-1028 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Morishita R,Yamada S,Yamamoto K,Tomita N,Kida I,Sakurabayashi I,Kikuchi A,Kaneda Y,Lawn R,Higaki J,Ogihara T.: "Novel therapeutic strategy for atherosclerosis : ribozyme oligonucleotides against apolipoprotein (a) selectively inhibit apolipoprotein (a) , but not plasminogen, gene expression." Circulation. 98. 1898-1904 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawamura I,Morishita R,Tomita N,Elizabeth L,Aketa M,Tsujimoto S,Manda T,Tomoi M,Kida I,Higakai J,Kaneda Y,Ogihara T.: "Intratumoral injection of oligonucleotides to the NFkB binding site inhibits cachexia in a mouse tumor model." Gene Therapy. 6. 91-97 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-12-08  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi